Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCapricorn Energy PLC Regulatory News (CNE)

Share Price Information for Capricorn Energy PLC (CNE)

Share Price is delayed by 15 minutes
Get Live Data
284.00    -3.00 (-1.05%)
Bid:
282.00
Ask:
284.00
Spread: 2.00 (0.709%)
Market Cap: £195.01m
CNE Live PriceLast checked at - London Stock Exchange

Intraday Capricorn Energy PLC Share Chart

Board Changes

24 Jan 2023 07:00

RNS Number : 6646N
Capricorn Energy PLC
24 January 2023
 

FOR IMMEDIATE RELEASE 24 January 2023

 

CAPRICORN ENERGY PLC ("Capricorn" or "the Company")

 

Adjournment of General Meeting for shareholder vote on NewMed Energy Limited Partnership ("NewMed") Combination (the "NewMed GM")

 

Board Changes

 

The Capricorn Board's priority has been to ensure that the shareholder votes on both the proposed NewMed Combination and the Palliser requisitioned General Meeting on Board composition (the "Requisitioned GM") can occur. To date, it has been necessary to schedule the two votes on the same day to ensure that the option of the NewMed Combination could be maintained.

 

The Board has listened to shareholder concerns about the timing of the General Meetings, and has therefore been considering the Company's obligations under the Business Combination Agreement entered into with NewMed on 29 September 2022 (the "Business Combination Agreement"), and discussing with the FCA the requirements of the combined prospectus and circular published by the Company on 13 January 2023 (the "Prospectus/Circular") and now intends for the NewMed GM to be adjourned from 1 February until 22 February 2023.

 

The Requisitioned GM will go ahead on 1 February 2023, with an adjournment of the NewMed GM allowing a reconstituted Board to assess the proposed NewMed Combination alongside other strategic options prior to determining the recommended route forward. NewMed is aware of the intended adjournment of the NewMed GM and has advised the Company that it reserves its rights under the Business Combination Agreement.

 

To best enable the process of Board reconstitution, the following changes to the Board have been collectively agreed:

 

-

Nicoletta Giadrossi has accelerated her decision to step down as Chair following the proposed NewMed Combination vote, and will step down from the Board with immediate effect;

-

Simon Thomson will step down as a Board director with immediate effect;

-

Peter Kallos, Alison Wood and Luis Araujo will also step down from the Board with immediate effect;

-

Keith Lough remains on the Board to ensure ongoing oversight of reporting obligations and other corporate governance requirements with the intention of stepping down from the Board in advance of the Requisitioned GM; and

-

similarly, James Smith remains on the Board as Chief Financial Officer, with the intention of stepping down from his role as Board director in advance of the Requisitioned GM.

 

 

The Company has been in discussions, via Palliser, with the Requisitioned GM nominee directors (the "Nominee Directors") to seek to appoint them to the Board immediately, but understands that the Nominee Directors' preference is to wait until the Requisitioned GM on 1 February. The continuing directors, including Cathy Krajicek and Erik B. Daugbjerg, will engage with the Nominee Directors to ensure an orderly transition and appropriate continuity of governance. A further announcement on Board reconstitution will be made in due course.

 

A document supplementing the Prospectus/Circular on this and any other relevant matters will be issued in due course as required.

 

 

Enquiries to:

 

Analysts / Investors

 

David Nisbet, Corporate Affairs

Tel: 0131 475 3000

 

Media

 

Jonathan Milne/Linda Bain, Corporate Affairs

Tel: 0131 475 3000

 

 

Patrick Handley, David Litterick

Brunswick Group LLP

 

Tel: 0207 404 5959

 

About Capricorn Energy PLC

Capricorn Energy PLC is one of Europe's leading independent upstream energy companies, headquartered in Edinburgh, UK. Historically we have discovered, developed and produced oil and gas in multiple settings throughout the world. Today our focus is on growing our current gas and liquids production base through development and exploration, with an ambition to use our strong balance sheet to expand that production base into other attractive markets and to commercialise exploration resources. We adhere to high sustainability standards, we invest to ensure our portfolio remains competitive through stringent energy transition scenarios and we are committed to net zero carbon emissions by 2040.

 

Disclaimers

 

This announcement has been issued by and is the sole responsibility of Capricorn. The information contained in this announcement is for information purposes only and does not purport to be complete. The information in this announcement is subject to change. This announcement has been prepared in accordance with English law, the UK Market Abuse Regulation and the Disclosure Guidance and Transparency Rules and Listing Rules of the FCA. Information disclosed may not be the same as that which would have been prepared in accordance with the laws of jurisdictions outside England.

 

Takeover Code disclosure

 

In accordance with Rule 26.1 of the Code, a copy of this announcement and certain other documents required to be published pursuant to Rule 26 of the Code will be available (subject to certain restrictions relating to persons resident in restricted jurisdictions) at www.capricornenergy.com by no later than 12 noon (London time) on the business day following the date of this announcement. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement. Statements of estimated cost savings and synergies relate to future actions and circumstances which, by their nature, involve risks, uncertainties and contingencies. As a result, any cost savings and synergies referred to may not be achieved, may be achieved later or sooner than estimated, or those achieved could be materially different from those estimated. No statement in this document should be construed as a profit forecast or interpreted to mean that the combined group's earnings in the first full year following implementation of the Combination, or in any subsequent period, would necessarily match or be greater than or be less than those of NewMed or Capricorn for the relevant preceding financial period or any other period.

 

Additional Information

 

This announcement is not intended to, and does not, constitute or form part of any offer, invitation, or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to this announcement or otherwise. Any offer, if made, will be made solely by certain offer documentation which will contain the full terms and conditions of any offer, including details of how it may be accepted. The distribution of this announcement in jurisdictions other than the United Kingdom and the availability of any offer to shareholders of Capricorn who are not resident in the United Kingdom may be affected by the laws of relevant jurisdictions. Therefore any persons who are subject to the laws of any jurisdiction other than the United Kingdom or shareholders of Capricorn who are not resident in the United Kingdom should inform themselves about, and observe any applicable requirements. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.

 

The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

 

For further information on Capricorn please see: www.capricornenergy.com

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASESSILEDSEFF
Date   Source Headline
3rd Jul 20237:00 amRNSTransaction in Own Shares
30th Jun 202311:37 amRNSReport on Payments to Govts
30th Jun 20239:38 amRNSTotal Voting Rights
30th Jun 20237:00 amRNSTransaction in Own Shares
29th Jun 20237:00 amRNSTransaction in Own Shares
28th Jun 20237:00 amRNSTransaction in Own Shares
27th Jun 20237:00 amRNSTransaction in Own Shares
26th Jun 20234:24 pmRNSResult of AGM
26th Jun 20239:10 amRNSReplacement AGM CEO and Chair Statements
26th Jun 20237:00 amRNSAGM Chief Executive’s and Chair’s Statements
26th Jun 20237:00 amRNSTransaction in Own Shares
23rd Jun 20237:00 amRNSTransaction in Own Shares
22nd Jun 20237:00 amRNSTransaction in Own Shares
21st Jun 20237:00 amRNSTransaction in Own Shares
20th Jun 20237:00 amRNSTransaction in Own Shares
19th Jun 20237:00 amRNSTransaction in Own Shares
16th Jun 20237:00 amRNSTransaction in Own Shares
15th Jun 20237:00 amRNSTransaction in Own Shares
14th Jun 20237:00 amRNSTransaction in Own Shares
13th Jun 20237:00 amRNSTransaction in Own Shares
12th Jun 20237:00 amRNSTransaction in Own Shares
9th Jun 20237:00 amRNSTransaction in Own Shares
8th Jun 20237:00 amRNSTransaction in Own Shares
7th Jun 20237:00 amRNSTransaction in Own Shares
6th Jun 20237:00 amRNSTransaction in Own Shares
5th Jun 20237:00 amRNSTransaction in Own Shares
2nd Jun 20237:00 amRNSTransaction in Own Shares
1st Jun 20237:00 amRNSTransaction in Own Shares
31st May 202312:08 pmRNSCompany Secretary Change
31st May 202310:32 amRNSTotal Voting Rights
31st May 20237:00 amRNSTransaction in Own Shares
30th May 20237:00 amRNSTransaction in Own Shares
26th May 20237:00 amRNSTransaction in Own Shares
25th May 20233:57 pmRNSAnnual Financial Report
25th May 20237:26 amRNSTransaction in Own Shares
24th May 20238:27 amRNSHolding(s) in Company
24th May 20237:15 amRNSTransaction in Own Shares
23rd May 20237:29 amRNSTransaction in Own Shares
22nd May 20237:15 amRNSTransaction in Own Shares
19th May 202310:43 amRNSHolding(s) in Company
19th May 20237:17 amRNSTransaction in Own Shares
18th May 20239:59 amRNSDirectorate Change
18th May 20237:20 amRNSTransaction in Own Shares
17th May 20232:31 pmRNSHolding(s) in Company
17th May 20237:17 amRNSTransaction in Own Shares
16th May 20237:00 amRNSTotal Voting Rights
15th May 20231:49 pmRNSResult of Meeting
12th May 20238:27 amRNSHolding(s) in Company
11th May 202312:31 pmRNSDirector/PDMR Shareholding
11th May 20237:19 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.